APA (7th ed.) Citation

Zou, H., Liu, W., Wang, Y., Shan, D., Xie, T., Li, R., . . . Hao, X. (2024). Favorable outcomes of front-line risk-adapted therapy in young patients with diffuse large B-cell lymphoma with clinically or biologically high-risk features. Chinese Medical Journal, 137(13), 1620-1622. https://doi.org/10.1097/CM9.0000000000002940

Chicago Style (17th ed.) Citation

Zou, Hesong, et al. "Favorable Outcomes of Front-line Risk-adapted Therapy in Young Patients with Diffuse Large B-cell Lymphoma with Clinically or Biologically High-risk Features." Chinese Medical Journal 137, no. 13 (2024): 1620-1622. https://doi.org/10.1097/CM9.0000000000002940.

MLA (9th ed.) Citation

Zou, Hesong, et al. "Favorable Outcomes of Front-line Risk-adapted Therapy in Young Patients with Diffuse Large B-cell Lymphoma with Clinically or Biologically High-risk Features." Chinese Medical Journal, vol. 137, no. 13, 2024, pp. 1620-1622, https://doi.org/10.1097/CM9.0000000000002940.